Clinical Trials Directory

Trials / Completed

CompletedNCT02370914

Concussion Testing: A Novel Non-invasive Concussion Detection Device

Status
Completed
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
Jan Medical, Inc. · Industry
Sex
Male
Age
14 Years – 18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to establish and evaluate a distinctive signal for concussion.

Detailed description

The purpose of this study is to establish a non-invasive objective measurement for the detection of concussions with the Jan Medical Device (JMD). The study will assess the ability of this device to demonstrate unique signals that correlate with concussions. The study will also test the athletes at baseline at rest and during exertion to determine if there is a difference in the signal from exertion alone. The JMD is a non-invasive band that is placed around the participants head. The JMD detects a unique pattern of signals based on displacement of the skull from changes in blood flow during individual heartbeats. The athletes will be tested longitudinally to assess to changes over time, in addition to changes after impact

Conditions

Interventions

TypeNameDescription
DEVICENautilus NeuroWaveTM SystemRecording of subjects with Nautilus NeuroWave diagnostic device
BEHAVIORALSCATA Neurocognitive evaluation of the patients to assess for concussion.

Timeline

Start date
2011-08-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2015-02-25
Last updated
2022-08-02
Results posted
2017-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02370914. Inclusion in this directory is not an endorsement.